Clinical Trial Update: Gastroprotective Agent Compliance in Patients at Risk Suffering From a Gastrointestinal(GI) Ulcer

View source ↗

Summary

A clinical trial investigating a gastroprotective agent for patients at risk with a gastrointestinal ulcer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Ulcer
• Gastrointestinal Hemorrhage

Snippet

Sponsor: AstraZeneca | Conditions: Gastrointestinal Hemorrhage, Ulcer | Status: WITHDRAWN